Business Description
IR-Med Inc
NAICS : 325413
SIC : 5047
ISIN : US46265R1032
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.55 | |||||
Equity-to-Asset | -0.15 | |||||
Debt-to-Equity | -1.86 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -86.2 | |||||
3-Year EPS without NRI Growth Rate | -85.3 | |||||
3-Year FCF Growth Rate | -98.6 | |||||
3-Year Book Growth Rate | -39 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 8.44 | |||||
9-Day RSI | 21.05 | |||||
14-Day RSI | 28.12 | |||||
6-1 Month Momentum % | -46.63 | |||||
12-1 Month Momentum % | 11.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.92 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.7 | |||||
Shareholder Yield % | 0.14 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -403.91 | |||||
ROA % | -252.58 | |||||
ROIC % | -1712.84 | |||||
ROC (Joel Greenblatt) % | -2706.68 | |||||
ROCE % | -367.33 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -10.16 | |||||
EV-to-Forward-EBIT | -10.71 | |||||
EV-to-EBITDA | -10.22 | |||||
EV-to-Forward-EBITDA | -13.14 | |||||
EV-to-Forward-Revenue | 42.85 | |||||
EV-to-FCF | -15.93 | |||||
Earnings Yield (Greenblatt) % | -9.84 | |||||
FCF Yield % | -6.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
IR-Med Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.07 | ||
Beta | 1.91 | ||
Volatility % | 187.76 | ||
14-Day RSI | 28.12 | ||
14-Day ATR ($) | 0.041991 | ||
20-Day SMA ($) | 0.815249 | ||
12-1 Month Momentum % | 11.39 | ||
52-Week Range ($) | 0.551 - 1.65 | ||
Shares Outstanding (Mil) | 71.83 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IR-Med Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IR-Med Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
IR-Med Inc Frequently Asked Questions
What is IR-Med Inc(IRME)'s stock price today?
When is next earnings date of IR-Med Inc(IRME)?
Does IR-Med Inc(IRME) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |